| Greg W. Kofford, Dc | |
|
246 S 1100 E American Fork UT 84003-2829 | |
| (801) 756-8833 | |
| (801) 756-9014 |
| Full Name | Greg W. Kofford, Dc |
|---|---|
| Speciality | Clinic/Center |
| Location | 246 S 1100 E, American Fork, Utah |
| Authorized Official Name and Position | Greg W Kofford (OWNER) |
| Authorized Official Contact | 8017568833 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Greg W. Kofford, Dc 246 S 1100 E American Fork UT 84003-2829 Ph: (801) 756-8833 | Greg W. Kofford, Dc 246 S 1100 E American Fork UT 84003-2829 Ph: (801) 756-8833 |
| NPI Number | 1194026914 |
|---|---|
| Provider Enumeration Date | 11/10/2010 |
| Last Update Date | 11/10/2010 |
| Medicare PECOS PAC ID | 5294916292 |
|---|---|
| Medicare Enrollment ID | O20110224000078 |
News Archive
Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta® (methylphenidate hydrochloride) extended-release 54 mg tablets.
Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194026914 | NPI | - | NPPES |
| 564570268002 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 363413 1202 (Utah) | Primary |
| Provider Name | Greg W Kofford |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1043307689 PECOS PAC ID: 7214996800 Enrollment ID: I20041008000405 |
News Archive
Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta® (methylphenidate hydrochloride) extended-release 54 mg tablets.
Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
› Verified 3 days ago
News Archive
Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta® (methylphenidate hydrochloride) extended-release 54 mg tablets.
Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
The Obama administration hires a credit reporting agency to verify the incomes of people who apply for federal subsidies to buy health insurance. Meanwhile, Missouri Gov. Jay Nixon signs a bill that could make it more difficult to do enrollment outreach there, as federal officials consider ways to implement the law in states led by officials opposed to it.
› Verified 3 days ago
Cpt Ctr Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 98 N West State Rd, American Fork, UT 84003 Phone: 877-292-4242 | |
Medical Accident Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1248 E 90 N Ste 203, American Fork, UT 84003 Phone: 385-498-7506 Fax: 385-498-7507 | |
Revere Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1175 E 50 S, American Fork, UT 84003 Phone: 801-429-8000 Fax: 801-429-8150 | |
Ihc Health Services Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-7414 | |
Provider Services Network, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 765 E 340 S Ste 206, American Fork, UT 84003 Phone: 801-893-1130 | |
Concord Premium Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 356 N 750 W, Ste D9-213, American Fork, UT 84003 Phone: 801-300-5159 |